SIRT3 and kidney disorder: Based on the above evidence, we sought here to evaluate whether SIRT3 activation through honokiol can confer protection against renal disease progression in BTBR ob/ob mice, which reproduce key features of human DN better than most murine models type 2 DN18–20, starting the treatment at an established phase of the disease to better mimic the condition in humans.